Clinical Trials Logo

Endoscopic Sleeve Gastroplasty clinical trials

View clinical trials related to Endoscopic Sleeve Gastroplasty.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03124485 Not yet recruiting - Clinical trials for Endoscopic Sleeve Gastroplasty

Endoscopic Sleeve Gastroplasty for Morbid Obesity

Start date: August 2017
Phase: N/A
Study type: Interventional

Obesity and its related metabolic disorders are increasingly a heavy health burden to many parts of the world. Weight control is a well-known important step in avoiding type 2 diabetes mellitus (T2DM). It is also an essential component for normalizing the blood glucose and preventing macrovascular and microvascular insults to patients with diagnosed T2DM. However, life-style modification, physical exercise and dietary adjustment are ineffective measures which are unlikely to confer adequate and sustainable weight loss for the truly obese. On the other hand, large scale long-term follow-up studies have confirmed the role of bariatric surgery in providing durable weight loss and remarkable improvement on medical comorbidities. Among all the bariatric operations, laparoscopic sleeve gastrectomy (LSG) is currently the most widely adopted procedure worldwide because of its simplicity and effectiveness in weight reduction. However, LSG is not without risk. Staple-line hemorrhage, leakage and stenosis are potentially life-threatening complications. LSG is also costly because of the need for expensive laparoscopic staplers.